Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03729609
Brief Title: Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion "Untreated CD30-Positive Hodgkin's Lymphoma"

First Submitted : October 30, 2018
First Submitted that Met QC Criteria : November 1, 2018
First Posted : November 2, 2018

Last Update Submitted that Met QC Criteria : March 23, 2021
Last Update Posted : March 26, 2021